|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.550 USD | -0.44% |
|
+17.57% | -21.55% |
| 06-18 | Coya Therapeutics Presents Alstars Trial Design At Encals 2026 Meeting | CI |
| 06-08 | Coya Therapeutics Says Phase 2 ALS Study Enters Blinded Extension Phase | MT |
| Market Cap | 107M 92.44M 86.17M 79.25M 150M 10.15B 151M 1.01B 397M 5.08B 401M 392M 16.82B | P/E 2026 * |
-3.35x | P/E 2027 * | -3.28x |
|---|---|---|---|---|---|
| Enterprise Value | 107M 92.44M 86.17M 79.25M 150M 10.15B 151M 1.01B 397M 5.08B 401M 392M 16.82B | EV / Sales 2026 * |
45.5x | EV / Sales 2027 * | 21.5x |
| Free-Float |
82.05% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Coya Therapeutics, Inc.
| 1 day | -0.44% | ||
| 1 week | +17.57% | ||
| Current month | +8.59% | ||
| 1 month | -22.35% | ||
| 3 months | +7.06% | ||
| 6 months | +2.94% | ||
| Current year | -21.55% |
| 1 week | 4 |  | 4.67 |
| 1 month | 3.86 | | 5.88 |
| Current year | 3.71 | | 6.21 |
| 1 year | 3.71 | | 7.75 |
| 3 years | 3.21 | | 10.69 |
| 5 years | 3.21 | | 10.69 |
| 10 years | 3.21 | | 10.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arun Swaminathan
CEO | Chief Executive Officer | 57 | 2024-10-31 |
Fred Grossman
PSD | President | 67 | 2023-07-16 |
David Snyder
DFI | Director of Finance/CFO | 65 | 2022-03-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Dov Goldstein
BRD | Director/Board Member | 58 | 2021-02-28 |
| Director/Board Member | 67 | 2021-05-24 | |
Ann Lee
BRD | Director/Board Member | 64 | 2021-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/22/26 | Free | Chief Financial Officer | 140,041 | 0.6693% | ||
| 1/22/26 | Free | Chief Executive Officer | 15,257 | 0.0729% | ||
| 1/22/26 | Free | Chairperson | 140,041 | 0.6693% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.44% | +17.57% | -29.24% | +19.74% | 107M | |
| +0.90% | -2.33% | +0.68% | +13.87% | 48B | |
| +1.98% | +9.05% | +413.94% | +532.17% | 41.13B | |
| +3.44% | -4.65% | +28.34% | +8.81% | 37.56B | |
| +1.40% | +0.10% | +6.61% | +61.93% | 35.91B | |
| +2.42% | +5.72% | +12.38% | +44.79% | 29.86B | |
| -0.16% | -3.11% | - | - | 16.12B | |
| +2.20% | +0.48% | +34.71% | +127.15% | 16.05B | |
| +1.25% | +1.52% | +4.62% | +18.26% | 13.76B | |
| +4.25% | -8.23% | -1.49% | -35.46% | 12.1B | |
| Average | +1.72% | +1.08% | +52.28% | +87.92% | 25.06B | |
| Weighted average by Cap. | +1.91% | +0.00% | +82.43% | +120.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.35M 2.03M 1.9M 1.74M 3.29M 223M 3.33M 22.27M 8.74M 112M 8.82M 8.62M 370M | 4.96M 4.3M 4.01M 3.68M 6.96M 472M 7.03M 47.07M 18.48M 236M 18.64M 18.22M 782M |
| Net income | -30.98M -26.83M -25.01M -23M -43.42M -2.95B -43.91M -294M -115M -1.47B -116M -114M -4.88B | -32.16M -27.86M -25.97M -23.88M -45.09M -3.06B -45.59M -305M -120M -1.53B -121M -118M -5.07B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-05 | US$4.550 | -0.44% | 99,666 |
| 26-08-04 | US$4.570 | +3.16% | 145,677 |
| 26-08-03 | US$4.430 | +5.73% | 116,954 |
| 26-07-31 | US$4.190 | +2.70% | 179,952 |
| 26-07-30 | US$4.080 | +5.43% | 151,355 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COYA Stock
Select your edition
All financial news and data tailored to specific country editions
